173 related articles for article (PubMed ID: 24367151)
1. Molecular aspects of poliovirus pathogenesis.
Nomoto A
Proc Jpn Acad Ser B Phys Biol Sci; 2007 Dec; 83(8):266-75. PubMed ID: 24367151
[TBL] [Abstract][Full Text] [Related]
2. Recent insights into poliovirus pathogenesis.
Ohka S; Nomoto A
Trends Microbiol; 2001 Oct; 9(10):501-6. PubMed ID: 11597452
[TBL] [Abstract][Full Text] [Related]
3. The molecular basis of poliovirus neurovirulence.
Ohka S; Nomoto A
Dev Biol (Basel); 2001; 105():51-8. PubMed ID: 11763337
[TBL] [Abstract][Full Text] [Related]
4. Retrograde transport of intact poliovirus through the axon via the fast transport system.
Ohka S; Yang WX; Terada E; Iwasaki K; Nomoto A
Virology; 1998 Oct; 250(1):67-75. PubMed ID: 9770421
[TBL] [Abstract][Full Text] [Related]
5. Transgenic mice carrying the human poliovirus receptor: new animal models for study of poliovirus neurovirulence.
Horie H; Koike S; Kurata T; Sato-Yoshida Y; Ise I; Ota Y; Abe S; Hioki K; Kato H; Taya C
J Virol; 1994 Feb; 68(2):681-8. PubMed ID: 8289371
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of dissemination pathways for poliovirus].
Ohka S
Uirusu; 2009 Jun; 59(1):107-14. PubMed ID: 19927995
[TBL] [Abstract][Full Text] [Related]
7. Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype.
Rezapkin GV; Fan L; Asher DM; Fibi MR; Dragunsky EM; Chumakov KM
Virology; 1999 May; 258(1):152-60. PubMed ID: 10329577
[TBL] [Abstract][Full Text] [Related]
8. Poliovirus trafficking toward central nervous system via human poliovirus receptor-dependent and -independent pathway.
Ohka S; Nihei C; Yamazaki M; Nomoto A
Front Microbiol; 2012; 3():147. PubMed ID: 22529845
[TBL] [Abstract][Full Text] [Related]
9. Transgenic PVR Tg-1 mice for testing of poliovirus type 3 neurovirulence: comparison with monkey test.
Dragunsky E; Gardner D; Taffs R; Levenbook I
Biologicals; 1993 Sep; 21(3):233-7. PubMed ID: 8117436
[TBL] [Abstract][Full Text] [Related]
10. Reduced mouse neurovirulence of poliovirus type 2 Lansing antigenic variants selected with monoclonal antibodies.
La Monica N; Kupsky WJ; Racaniello VR
Virology; 1987 Dec; 161(2):429-37. PubMed ID: 2825415
[TBL] [Abstract][Full Text] [Related]
11. Development of a neurovirulent testing system for oral poliovirus vaccine with transgenic mice.
Levenbook I; Nomura T
Lab Anim Sci; 1997 Apr; 47(2):118-20. PubMed ID: 9150487
[TBL] [Abstract][Full Text] [Related]
12. Tissue-specific replicating capacity of a chimeric poliovirus that carries the internal ribosome entry site of hepatitis C virus in a new mouse model transgenic for the human poliovirus receptor.
Yanagiya A; Ohka S; Hashida N; Okamura M; Taya C; Kamoshita N; Iwasaki K; Sasaki Y; Yonekawa H; Nomoto A
J Virol; 2003 Oct; 77(19):10479-87. PubMed ID: 12970433
[TBL] [Abstract][Full Text] [Related]
13. The pathogenesis of poliomyelitis: what we don't know.
Nathanson N
Adv Virus Res; 2008; 71():1-50. PubMed ID: 18585526
[TBL] [Abstract][Full Text] [Related]
14. A mouse model for poliovirus neurovirulence identifies mutations that attenuate the virus for humans.
La Monica N; Almond JW; Racaniello VR
J Virol; 1987 Sep; 61(9):2917-20. PubMed ID: 3039178
[TBL] [Abstract][Full Text] [Related]
15. Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice.
Abe S; Ota Y; Koike S; Kurata T; Horie H; Nomura T; Hashizume S; Nomoto A
Virology; 1995 Feb; 206(2):1075-83. PubMed ID: 7856082
[TBL] [Abstract][Full Text] [Related]
16. Transgenic mice as an alternative to monkeys for neurovirulence testing of live oral poliovirus vaccine: validation by a WHO collaborative study.
Dragunsky E; Nomura T; Karpinski K; Furesz J; Wood DJ; Pervikov Y; Abe S; Kurata T; Vanloocke O; Karganova G; Taffs R; Heath A; Ivshina A; Levenbook I
Bull World Health Organ; 2003; 81(4):251-60. PubMed ID: 12764491
[TBL] [Abstract][Full Text] [Related]
17. Host range phenotype induced by mutations in the internal ribosomal entry site of poliovirus RNA.
Shiroki K; Ishii T; Aoki T; Ota Y; Yang WX; Komatsu T; Ami Y; Arita M; Abe S; Hashizume S; Nomoto A
J Virol; 1997 Jan; 71(1):1-8. PubMed ID: 8985316
[TBL] [Abstract][Full Text] [Related]
18. Studies on neurovirulence in poliovirus-sensitive transgenic mice and cynomolgus monkeys for the different temperature-sensitive viruses derived from the Sabin type 3 virus.
Abe S; Ota Y; Doi Y; Nomoto A; Nomura T; Chumakov KM; Hashizume S
Virology; 1995 Jun; 210(1):160-6. PubMed ID: 7793068
[TBL] [Abstract][Full Text] [Related]
19. Mouse neurovirulence determinants of poliovirus type 1 strain LS-a map to the coding regions of capsid protein VP1 and proteinase 2Apro.
Lu HH; Yang CF; Murdin AD; Klein MH; Harber JJ; Kew OM; Wimmer E
J Virol; 1994 Nov; 68(11):7507-15. PubMed ID: 7933134
[TBL] [Abstract][Full Text] [Related]
20. [Mouse neurovirulence of antigenic chimeras (type I/II) of polioviruses].
Dai C
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Feb; 15(1):34-8. PubMed ID: 7686824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
